Connection

William Groh to Defibrillators, Implantable

Back to Details
This is a "connection" page, showing publications William Groh has written about Defibrillators, Implantable.
William Groh
Connection Strength
3.327
Defibrillators, Implantable
  1. Change in cognitive function over 12 months among patients with an implantable cardioverter-defibrillator. J Cardiovasc Nurs. 2013 Nov-Dec; 28(6):E28-36.
    View in: PubMed
    Score: 0.348
  2. You shouldn't take it with you: postmortem device reuse. Heart Rhythm. 2012 Feb; 9(2):215-6.
    View in: PubMed
    Score: 0.306
  3. Pacemaker and implantable cardioverter-defibrillator use in a US myotonic dystrophy type 1 population. J Cardiovasc Electrophysiol. 2011 Dec; 22(12):1369-75.
    View in: PubMed
    Score: 0.303
  4. A retrospective analysis of proceduralist-directed, nurse-administered propofol sedation for implantable cardioverter-defibrillator procedures. Heart Rhythm. 2012 Mar; 9(3):342-6.
    View in: PubMed
    Score: 0.302
  5. Validity and reliability of the chronic heart failure questionnaire mastery subscale in patients with defibrillators. West J Nurs Res. 2009 Dec; 31(8):1057-75.
    View in: PubMed
    Score: 0.265
  6. Physical function of patients with implantable cardioverter-defibrillators. J Cardiovasc Nurs. 2009 Sep-Oct; 24(5):398-409.
    View in: PubMed
    Score: 0.261
  7. Pacemaker/implantable cardioverter-defibrillator problem: right ventricular lead missensing in a biventricular implantable cardioverter-defibrillator. Heart Rhythm. 2008 Jan; 5(1):158-9.
    View in: PubMed
    Score: 0.227
  8. Lessons from a population: the limitations of left ventricular ejection fraction as the major determinant for primary prevention implantable cardioverter-defibrillators. J Am Coll Cardiol. 2006 Mar 21; 47(6):1167-8.
    View in: PubMed
    Score: 0.204
  9. Come see the softer side of clinical outcomes: Quality-of-life measures in implanted defibrillator trials. J Cardiovasc Electrophysiol. 2004 Mar; 15(3):292-4.
    View in: PubMed
    Score: 0.178
  10. Increase in ventricular tachycardia frequency after biventricular implantable cardioverter defibrillator upgrade. J Cardiovasc Electrophysiol. 2003 Nov; 14(11):1245-7.
    View in: PubMed
    Score: 0.174
  11. Amiodarone reduces the prevalence of T wave alternans in a population with ventricular tachyarrhythmias. J Cardiovasc Electrophysiol. 1999 Oct; 10(10):1335-9.
    View in: PubMed
    Score: 0.131
  12. Interactions between electronic article surveillance systems and implantable cardioverter-defibrillators. Circulation. 1999 Jul 27; 100(4):387-92.
    View in: PubMed
    Score: 0.130
  13. Software error resulting in malfunction of an implantable cardioverter defibrillator. J Cardiovasc Electrophysiol. 1999 Jun; 10(6):871-3.
    View in: PubMed
    Score: 0.128
  14. Advances in the treatment of arrhythmias: implantable cardioverter-defibrillators. Am Fam Physician. 1998 Jan 15; 57(2):297-307, 310-2.
    View in: PubMed
    Score: 0.116
  15. Use of implantable cardioverter-defibrillators in the congenital long QT syndrome. Am J Cardiol. 1996 Sep 15; 78(6):703-6.
    View in: PubMed
    Score: 0.106
  16. Utilization rates of implantable cardioverter-defibrillators for primary prevention of sudden cardiac death: a 2012 calculation for a midwestern health referral region. Heart Rhythm. 2014 May; 11(5):849-55.
    View in: PubMed
    Score: 0.089
  17. Cardiac function tests in neuromuscular diseases. Neurol Clin. 2004 Aug; 22(3):591-617, vi.
    View in: PubMed
    Score: 0.046
  18. Ischemic ventricular arrhythmias during heart failure: a canine model to replicate clinical events. Heart Rhythm. 2005 Sep; 2(9):979-83.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.